Drug intelligence / Profile preview

Shouxuanbi Xiji

Development stage: Unknown
Administration: Topical

Overview

Shouxuanbi Xiji is a traditional Chinese medicine (TCM) topical wash formulated to treat Bi syndrome. Bi syndrome is characterized by pain, numbness, heaviness, and restricted movement in muscles, tendons, and joints, often attributed to external pathogenic factors such as wind, cold, dampness, and heat. The preparation is designed to promote blood circulation, dispel wind, expel cold, relieve pain, soften hardness, dissipate nodules, resolve stasis, and unblock meridians, thereby alleviating the symptoms associated with Bi syndrome.

Other names: 受宣痹洗剂

Targets

TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on Shouxuanbi Xiji.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shouxuanbi Xiji.

Explore the full profile